Thursday, February 19, 2026 2/19/2026

Generalized fluctuation test for deciphering phenotypic switching within cell populations

Award Number: R35GM148351
ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 03/01/2023
PERIOD OF PERFORMANCE END DATE: 12/31/2027

Group Awards By:

View Award Description

Generalized fluctuation test for deciphering phenotypic switching within cell populations - Generalized ﬂuctuation test for deciphering phenotypic switching within cell populations The inherent probabilistic nature of biochemical reactions coupled with low-copy number components results in signiﬁcant random ﬂuctuations (noise) in mRNA/protein levels inside individual cells. How cellular biochemical processes function reliably in the face of such randomness is an intriguing fundamental problem. A long-term vision of our lab is to develop new mathematical and computational tools for studying stochastic dynamics of cellular biochemical processes, and use these tools to systematically understand how noise affects biological function and phenotype. As a consequence of noise in gene product levels, single cells within an isoclonal population can differ in their expression proﬁle and reside in different pheno- typic states. The dynamic nature of this intercellular variation, where individual cells can transition between different states over time makes it a particularly hard phenomenon to characterize. Unexpectedly, phenotypic heterogeneity within a population can play important functional roles in diverse biological processes, from driving genetically-identical cells to different cell fates to allowing microbes and cancer cells to hedge their bets against uncertain environmental changes. The Luria-Delbrück experiment, also called the “Fluctuation Test , introduced 75 years ago, demonstrated that genetic mu- tations arise randomly in the absence of selection – rather than in response to selection – and led to a Nobel Prize. The innovation of this project is to leverage this classical experiment in conjunction with mathematical modeling to char- acterize reversible and irreversible switching between cell states. The key advantage of the proposed method is that it is general enough to be applied to any proliferating cell type, and only involves making a single endpoint measurement. This is especially important for scenarios where a measurement involves killing the cell (for example, assaying whether a bacte- rial cell is in a drug-sensitive or drug-tolerant state or doing RNA-sequencing), and hence the state of the same cell cannot be measured at different time points. The project will develop mathematical tools for characterizing phenotypic switching between an arbitrary number of states using the ﬂuctuation test, and such techniques will for the ﬁrst time differentiate between an irreversible cell-state transition via genetic alterations vs. a reversible epigenetic transition. These tools will be ﬁrst benchmarked with in-silico generated data and then applied on experimental datasets investigating diverse prob- lems, including characterizing drug-tolerant states in bacterial/fungal cells, understanding differences in viral susceptibility between single human cells within the same clonal population, and uncovering the transient dynamics of stem cell states that bias individual cells to different differentiation fates. Our preliminary work reveals plasticity in drug-tolerant states in bacterial, fungal, and cancer cells with different inheritance timescales. To understand the origins of cell states, the project will develop computational tools for inferring causal interaction networks from single-cell expression data. These tools will uncover how network topologies change across cell states and modeling the stochastic dynamics of underlying biochemical networks will mechanistically capture transitions between states. Overall, tools developed through this project will result in a fundamental understanding of how single-cell difference arises from stochastic epigenetic processes without any changes to DNA, and drive translational approaches to perturb cell states for therapeutic beneﬁt.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $351,191 )
2026	2026	UNIVERSITY OF DELAWARE	550 S COLLEGE AVE	NEWARK	DE	19713	NEW CASTLE	USA	Biomedical Research and Research Training	000	4	1/16/2026	NON-COMPETING CONTINUATION	$351,191
														Subtotal = $351,191

Issue Date FY: 2025 ( Subtotal = $390,611 )
2025	2025	UNIVERSITY OF DELAWARE	550 S COLLEGE AVE	NEWARK	DE	19713	NEW CASTLE	USA	Biomedical Research and Research Training	001	3	12/17/2024	NON-COMPETING CONTINUATION	$351,550
2025	2025	UNIVERSITY OF DELAWARE	550 S COLLEGE AVE	NEWARK	DE	19713	NEW CASTLE	USA	Biomedical Research and Research Training	002	3	8/12/2025	NON-COMPETING CONTINUATION	$39,061
2025	2024	UNIVERSITY OF DELAWARE	550 S COLLEGE AVE	NEWARK	DE	19713	NEW CASTLE	USA	Biomedical Research and Research Training	000	2	11/15/2024	NON-COMPETING CONTINUATION	$0
														Subtotal = $390,611

Issue Date FY: 2024 ( Subtotal = $390,995 )
2024	2024	UNIVERSITY OF DELAWARE	220 HULLIHEN HALL	NEWARK	DE	19716	NEW CASTLE	USA	Biomedical Research and Research Training	001	2	7/2/2024	NON-COMPETING CONTINUATION	$39,100
2024	2024	UNIVERSITY OF DELAWARE	220 HULLIHEN HALL	NEWARK	DE	19716	NEW CASTLE	USA	Biomedical Research and Research Training	000	2	12/15/2023	NON-COMPETING CONTINUATION	$351,895
														Subtotal = $390,995

Issue Date FY: 2023 ( Subtotal = $391,362 )
2023	2023	UNIVERSITY OF DELAWARE	220 HULLIHEN HALL	NEWARK	DE	19716	NEW CASTLE	USA	Biomedical Research and Research Training	000	1	2/8/2023	NEW	$391,362
														Subtotal = $391,362

Grand Total All Awards = $1,524,159

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Generalized fluctuation test for deciphering phenotypic switching within cell populations

Award Number: R35GM148351

ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 03/01/2023

PERIOD OF PERFORMANCE END DATE: 12/31/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer